Adam Woodrow Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Adam Woodrow.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Adam Woodrow. Adam Woodrow is President & Chief Commercial in Paratek Pharmaceuticals, Inc. ($PRTK) and VP & Chief Commercial Officer in Paratek Pharmaceuticals, Inc. ($PRTK).
Latest Insider Trading Transactions of Adam Woodrow
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 01 2021 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | President & Chief C ... | Grant | A | 0.00 | 177,750 | 0 | 449,023 | 271.3 K to 449 K (+65.52 %) |
| Dec 15 2020 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | President & Chief C ... | Sell | S | 6.71 | 12,855 | 86,257 | 271,273 | 284.1 K to 271.3 K (-4.52 %) |
| Dec 15 2020 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | President & Chief C ... | Sell | S | 6.95 | 9,045 | 62,863 | 284,128 | 293.2 K to 284.1 K (-3.09 %) |
| Nov 16 2020 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | President & Chief C ... | Sell | S | 5.93 | 15,000 | 88,950 | 293,173 | 308.2 K to 293.2 K (-4.87 %) |
| Nov 16 2020 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | President & Chief C ... | Grant | A | 0.00 | 37,500 | 0 | 308,173 | 270.7 K to 308.2 K (+13.85 %) |
| May 14 2020 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | President & Chief C ... | Sell | S | 4.75 | 4,798 | 22,791 | 270,673 | 275.5 K to 270.7 K (-1.74 %) |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | President & Chief C ... | Grant | A | 0.00 | 67,500 | 0 | 275,471 | 208 K to 275.5 K (+32.46 %) |
| Dec 16 2019 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | President & Chief C ... | Sell | S | 3.10 | 4,401 | 13,643 | 207,971 | 212.4 K to 208 K (-2.07 %) |
| Oct 08 2019 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | President & Chief C ... | Sell | S | 3.82 | 5,322 | 20,330 | 212,372 | 217.7 K to 212.4 K (-2.44 %) |
| Oct 08 2019 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | President & Chief C ... | Grant | A | 0.00 | 13,000 | 0 | 217,694 | 204.7 K to 217.7 K (+6.35 %) |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Grant | A | 0.00 | 60,000 | 0 | 204,694 | 144.7 K to 204.7 K (+41.47 %) |
| Feb 07 2019 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 6.77 | 3,331 | 22,551 | 144,694 | 148 K to 144.7 K (-2.25 %) |
| Feb 04 2019 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Grant | A | 0.00 | 16,250 | 0 | 148,025 | 131.8 K to 148 K (+12.33 %) |
| Dec 14 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 6.76 | 3,733 | 25,235 | 131,775 | 135.5 K to 131.8 K (-2.75 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 8.96 | 2,659 | 23,825 | 135,508 | 138.2 K to 135.5 K (-1.92 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 8.96 | 2,659 | 23,825 | 135,508 | 138.2 K to 135.5 K (-1.92 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Grant | A | 0.00 | 6,500 | 0 | 138,167 | 131.7 K to 138.2 K (+4.94 %) |
| Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Grant | A | 0.00 | 6,500 | 0 | 138,167 | 131.7 K to 138.2 K (+4.94 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 9.82 | 8,750 | 85,925 | 131,667 | 140.4 K to 131.7 K (-6.23 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Grant | A | 0.00 | 27,500 | 0 | 140,417 | 112.9 K to 140.4 K (+24.35 %) |
| Oct 04 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Grant | A | 0.00 | 23,750 | 0 | 112,917 | 89.2 K to 112.9 K (+26.64 %) |
| Apr 10 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 12.70 | 5,700 | 72,390 | 89,167 | 94.9 K to 89.2 K (-6.01 %) |
| Apr 10 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 12.70 | 5,700 | 72,390 | 89,167 | 94.9 K to 89.2 K (-6.01 %) |
| Apr 05 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Grant | A | 0.00 | 14,250 | 0 | 94,867 | 80.6 K to 94.9 K (+17.68 %) |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Grant | A | 0.00 | 29,250 | 0 | 80,617 | 51.4 K to 80.6 K (+56.94 %) |
| Feb 07 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 13.77 | 11,000 | 151,470 | 51,367 | 62.4 K to 51.4 K (-17.64 %) |
| Feb 07 2018 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 14.22 | 3,333 | 47,395 | 62,367 | 65.7 K to 62.4 K (-5.07 %) |
| Jul 06 2017 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Sell | S | 23.58 | 3,800 | 89,599 | 65,700 | 69.5 K to 65.7 K (-5.47 %) |
| Jul 06 2017 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Grant | A | 0.00 | 9,500 | 0 | 69,500 | 60 K to 69.5 K (+15.83 %) |
| Feb 06 2017 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Option Exercise | A | 15.10 | 47,500 | 717,250 | 47,500 | |
| Feb 08 2016 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Option Exercise | A | 14.05 | 50,000 | 702,500 | 50,000 | |
| Feb 08 2016 | PRTK | Paratek Pharmaceut ... | Woodrow Adam | VP & Chief Commerci ... | Grant | A | 0.00 | 25,000 | 0 | 60,000 | 35 K to 60 K (+71.43 %) |
Page: 1